Stacy L. Haber

582 total citations
27 papers, 434 citations indexed

About

Stacy L. Haber is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Surgery. According to data from OpenAlex, Stacy L. Haber has authored 27 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Public Health, Environmental and Occupational Health, 5 papers in Pharmacology and 4 papers in Surgery. Recurrent topics in Stacy L. Haber's work include Pharmacology and Obesity Treatment (4 papers), Innovations in Medical Education (4 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Stacy L. Haber is often cited by papers focused on Pharmacology and Obesity Treatment (4 papers), Innovations in Medical Education (4 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Stacy L. Haber collaborates with scholars based in United States, Czechia and Canada. Stacy L. Haber's co-authors include Scott Bolesta, Valérie Castellani, Susan Ellis, Tam Minh Pham, Shareen Y. El‐Ibiary, Richard R. Vaillancourt, Robert P. McMahon, Marion Slack, Matthew A. Wanat and Srikanth Kolluru and has published in prestigious journals such as SHILAP Revista de lepidopterología, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and Annals of Pharmacotherapy.

In The Last Decade

Stacy L. Haber

27 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stacy L. Haber United States 12 122 78 60 46 40 27 434
Renata Costa Fortes Brazil 13 80 0.7× 45 0.6× 49 0.8× 34 0.7× 43 1.1× 91 392
C.D. Tripathi India 9 31 0.3× 27 0.3× 45 0.8× 32 0.7× 40 1.0× 17 386
Reza Barati‐Boldaji Iran 12 138 1.1× 65 0.8× 21 0.3× 162 3.5× 65 1.6× 29 565
Frank Donath Germany 13 44 0.4× 71 0.9× 97 1.6× 14 0.3× 70 1.8× 33 646
Vijay Khajuria India 11 55 0.5× 78 1.0× 65 1.1× 22 0.5× 43 1.1× 71 529
Niti Mittal India 12 49 0.4× 23 0.3× 43 0.7× 7 0.2× 25 0.6× 50 390
SK Gupta India 14 76 0.6× 60 0.8× 37 0.6× 73 1.6× 105 2.6× 85 763
Sandra Mary Lima Vasconcelos Brazil 8 103 0.8× 38 0.5× 8 0.1× 68 1.5× 78 1.9× 32 617
Dongning Yao Macao 11 27 0.2× 37 0.5× 39 0.7× 19 0.4× 49 1.2× 30 333
Anjan Adhikari India 9 33 0.3× 45 0.6× 24 0.4× 16 0.3× 31 0.8× 68 373

Countries citing papers authored by Stacy L. Haber

Since Specialization
Citations

This map shows the geographic impact of Stacy L. Haber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacy L. Haber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacy L. Haber more than expected).

Fields of papers citing papers by Stacy L. Haber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacy L. Haber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacy L. Haber. The network helps show where Stacy L. Haber may publish in the future.

Co-authorship network of co-authors of Stacy L. Haber

This figure shows the co-authorship network connecting the top 25 collaborators of Stacy L. Haber. A scholar is included among the top collaborators of Stacy L. Haber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacy L. Haber. Stacy L. Haber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kolluru, Srikanth, Matthew A. Wanat, Stacy L. Haber, et al.. (2022). Review of Best Practices for Diversity, Equity, and Inclusion Committees Within Colleges of Pharmacy. American Journal of Pharmaceutical Education. 87(4). ajpe9043–ajpe9043. 7 indexed citations
2.
Haber, Stacy L., et al.. (2021). Amisulpride: A New Drug for Management of Postoperative Nausea and Vomiting. Annals of Pharmacotherapy. 55(10). 1276–1282. 3 indexed citations
3.
Haber, Stacy L., et al.. (2020). Effects of Moringa oleifera in patients with type 2 diabetes. American Journal of Health-System Pharmacy. 77(22). 1834–1837. 10 indexed citations
4.
Haber, Stacy L., et al.. (2018). Lesinurad: A Novel Agent for Management of Chronic Gout. Annals of Pharmacotherapy. 52(7). 690–696. 11 indexed citations
5.
Haber, Stacy L., et al.. (2018). Garcinia cambogia for weight loss. American Journal of Health-System Pharmacy. 75(2). 17–22. 33 indexed citations
6.
Haber, Stacy L. & Shareen Y. El‐Ibiary. (2015). Peppermint oil for treatment of irritable bowel syndrome. American Journal of Health-System Pharmacy. 73(2). 22–31. 12 indexed citations
7.
Haber, Stacy L., Kathleen A. Fairman, & David A. Sclar. (2015). Principles in the Evaluation of Systematic Reviews. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 35(11). 1077–1087. 2 indexed citations
8.
Haber, Stacy L., et al.. (2014). A leadership journal club for officers of a professional organization for pharmacy students. Currents in Pharmacy Teaching and Learning. 7(1). 112–116. 5 indexed citations
9.
Haber, Stacy L., et al.. (2013). Fenugreek use in patients with diabetes mellitus. American Journal of Health-System Pharmacy. 70(14). 1196–1203. 28 indexed citations
10.
Haber, Stacy L., et al.. (2013). Safety of Varenicline in Patients With Cardiovascular Disease. Journal of Pharmacy Practice. 27(1). 65–70. 3 indexed citations
11.
Haber, Stacy L., et al.. (2012). Effects of dark chocolate on blood pressure in patients with hypertension. American Journal of Health-System Pharmacy. 69(15). 1287–1293. 3 indexed citations
12.
Haber, Stacy L., et al.. (2012). Cranberry and Warfarin Interaction: A Case Report and Review of the Literature. The Consultant Pharmacist. 27(1). 58–65. 12 indexed citations
13.
Haber, Stacy L., et al.. (2012). An Evaluation of the Use of Oral Bisphosphonates and Risk of Esophageal Cancer. Annals of Pharmacotherapy. 46(3). 419–423. 14 indexed citations
14.
Haber, Stacy L., et al.. (2011). Elevated International Normalized Ratio Associated with Use of Dronedarone and Warfarin. Annals of Pharmacotherapy. 45(9). 1161–1161. 6 indexed citations
15.
Haber, Stacy L., et al.. (2011). Antioxidant and antiatherogenic effects of pomegranate. American Journal of Health-System Pharmacy. 68(14). 1302–1305. 12 indexed citations
16.
Haber, Stacy L., et al.. (2008). Prasugrel: A novel antiplatelet agent. American Journal of Health-System Pharmacy. 65(11). 1019–1028. 15 indexed citations
17.
Haber, Stacy L., et al.. (2007). Clinical uses of artichoke leaf extract. American Journal of Health-System Pharmacy. 64(18). 1904–1909. 50 indexed citations
18.
Bolesta, Scott & Stacy L. Haber. (2002). Hepatotoxicity Associated with Chronic Acetaminophen Administration in Patients Without Risk Factors. Annals of Pharmacotherapy. 36. 331–333. 3 indexed citations
19.
Haber, Stacy L.. (2000). Evidence-Based Clinical Practice: Concepts and Approaches. American Journal of Health-System Pharmacy. 57(23). 2235–2235. 6 indexed citations
20.
Haber, Stacy L.. (1980). Effective treatment of obesity produces remission, not cure.. PubMed. 4(3). 265–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026